RBC Capital Ups DGX To Outperform

Analysts at RBC Capital upgrade Quest Diagnostics Incorporated DGX from “sector perform” to “outperform.” The target price for DGX has been raised from $57 to $66. DGX shares gained 3.90% to close at $56.28 yesterday. More Analyst Ratings here